39 related articles for article (PubMed ID: 4550450)
1. Aberrant glycosylation of IgA in Wiskott-Aldrich syndrome and X-linked thrombocytopenia.
Shimizu M; Kanegane H; Wada T; Motoyoshi Y; Morio T; Candotti F; Yachie A
J Allergy Clin Immunol; 2013 Feb; 131(2):587-90.e1-3. PubMed ID: 23107152
[No Abstract] [Full Text] [Related]
2. Facial Skin Lesions in a Boy With Wiskott-Aldrich Syndrome.
Zhou YB; Wang S; Ma L; Wei L
Clin Infect Dis; 2023 Aug; 77(4):659-661. PubMed ID: 37607355
[No Abstract] [Full Text] [Related]
3. Translate or differentiate? Molecular mechanisms of ETV6-related thrombocytopenia.
Camacho V
J Thromb Haemost; 2023 Sep; 21(9):2367-2369. PubMed ID: 37597896
[No Abstract] [Full Text] [Related]
4. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome.
Litzman J; Jones A; Hann I; Chapel H; Strobel S; Morgan G
Arch Dis Child; 1996 Nov; 75(5):436-9. PubMed ID: 8957959
[TBL] [Abstract][Full Text] [Related]
5. Immunologic studies before and after splenectomy in a patient with the Wiskott-Aldrich syndrome.
Knutsen AP; Rosse WF; Kinney TR; Buckley RH
J Clin Immunol; 1981 Jan; 1(1):13-9. PubMed ID: 7334067
[TBL] [Abstract][Full Text] [Related]
6. Wiskott-Aldrich syndrome: new perspectives in pathogenesis and management.
Standen GR
J R Coll Physicians Lond; 1988 Apr; 22(2):80-3. PubMed ID: 3294390
[No Abstract] [Full Text] [Related]
7. Wiskott-Aldrich syndrome: a multidisciplinary disease.
Standen GR
J Clin Pathol; 1991 Dec; 44(12):979-82. PubMed ID: 1791213
[No Abstract] [Full Text] [Related]
8. [Chronic pseudomalignant immuneproliferation (Canale-Smith syndrome) (author's transl)].
Kellerer K; Mutz I
Eur J Pediatr; 1976 Feb; 121(3):203-13. PubMed ID: 1248492
[TBL] [Abstract][Full Text] [Related]
9. [Wiskott-Aldrich syndrome].
Gulácsy V; Maródi L
Orv Hetil; 2008 Jul; 149(29):1367-71. PubMed ID: 18617469
[TBL] [Abstract][Full Text] [Related]
10. Hereditary thrombocytopenia: relation to Wiskott-Aldrich syndrome with special reference to splenectomy. Report of a family and review of the literature.
Weiden PL; Blaese RM
J Pediatr; 1972 Feb; 80(2):226-34. PubMed ID: 4550450
[No Abstract] [Full Text] [Related]
11. Wiskott Aldrich syndrome: a treatable immune disorder. A review.
Millikan LE
Mo Med; 1973 Nov; 70(11):764-7 passim. PubMed ID: 4591682
[No Abstract] [Full Text] [Related]
12. The Wiskott-Aldrich syndrome. Immunologic studies in nine patients and selected family members.
Spitler LE; Levin AS; Stites DP; Fudenberg HH; Huber H
Cell Immunol; 1975 Oct; 19(2):201-18. PubMed ID: 1104190
[No Abstract] [Full Text] [Related]
13. X-linked recessive disorders: chronic granulomatous disease and Wiskott-Aldrich syndrome.
Mauer AM
J Invest Dermatol; 1973 Jun; 60(6):522-8. PubMed ID: 4575898
[No Abstract] [Full Text] [Related]
14. The Wiskott-Aldrich syndrome.
Ormerod AD
Int J Dermatol; 1985 Mar; 24(2):77-81. PubMed ID: 3886570
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
